The α₂ adrenergic antagonist fipamezole improves quality of levodopa action in Parkinsonian primates. [electronic resource]
Producer: 20110126Description: 2084-93 p. digitalISSN:- 1531-8257
- Adrenergic alpha-2 Receptor Antagonists -- pharmacology
- Analysis of Variance
- Animals
- Disability Evaluation
- Disease Models, Animal
- Dopamine Agents -- adverse effects
- Drug Therapy, Combination -- methods
- Dyskinesia, Drug-Induced -- drug therapy
- Female
- Imidazoles -- pharmacology
- Indans -- pharmacology
- Levodopa -- adverse effects
- Macaca fascicularis
- Male
- Motor Activity -- drug effects
- Parkinsonian Disorders -- drug therapy
- Time Factors
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.